Owing to positive correlations, CCL11 has become oneof the essential biological targets for detecting these diseases and hasmanifested differential regulation in different diseases or stages of diseaseprogression, indicating its potential to identify diverse aging-related diseases.Concurrently, a novel therapeutic strategy, anti-CCL11 therapy, was proposed andsuggested for neurodegenerative and cardiovascular diseases. The gene discussed is CCL11; the disease is cardiovascular disorder.